Sport and Health Sciences, College of Life and Environmental Sciences, St. Luke's Campus, University of Exeter, Heavitree Road, Exeter, UK.
Sport and Health Sciences, College of Life and Environmental Sciences, St. Luke's Campus, University of Exeter, Heavitree Road, Exeter, UK.
Nitric Oxide. 2017 Feb 28;63:13-20. doi: 10.1016/j.niox.2016.12.008. Epub 2016 Dec 23.
Uptake of inorganic nitrate (NO) into the salivary circulation is a rate-limiting step for dietary NO metabolism in mammals. It has been suggested that salivary NO uptake occurs in competition with inorganic iodide (I). Therefore, this study tested the hypothesis that I supplementation would interfere with NO metabolism and blunt blood pressure reductions after dietary NO supplementation. Nine healthy adults (4 male, mean ± SD, age 20 ± 1 yr) reported to the laboratory for initial baseline assessment (control) and following six day supplementation periods with 140 mL·day NO-rich beetroot juice (8.4 mmol NO·day) and 198 mg potassium gluconate·day (nitrate), and 140 mL·day NO-rich beetroot juice and 450 μg potassium iodide·day (nitrate + iodide) in a randomized, cross-over experiment. Salivary [I] was higher in the nitrate + iodide compared to the control and NIT trials (P < 0.05). Salivary and plasma [NO] and [NO] were higher in the nitrate and nitrate + iodide trials compared to the control trial (P < 0.05). Plasma [NO] was higher (474 ± 127 vs. 438 ± 117 μM) and the salivary-plasma [NO] ratio was lower (14 ± 6 vs. 20 ± 6 μM), indicative of a lower salivary NO uptake, in the nitrate + iodide trial compared to the nitrate trial (P < 0.05). Plasma and salivary [NO] were not different between the nitrate and nitrate + iodide trials (P > 0.05). Systolic blood pressure was lower than control (112 ± 13 mmHg) in the nitrate (106 ± 13 mmHg) and nitrate + iodide (106 ± 11 mmHg) trials (P < 0.05), with no differences between the nitrate and nitrate + iodide trials (P > 0.05). In conclusion, co-ingesting NO and I perturbed salivary NO uptake, but the increase in salivary and plasma [NO] and the lowering of blood pressure were similar compared to NO ingestion alone. Therefore, increased dietary I intake, which is recommended in several countries worldwide as an initiative to offset hypothyroidism, does not appear to compromise the blood pressure reduction afforded by increased dietary NO intake.
哺乳动物唾液中无机硝酸盐(NO)的摄取是膳食 NO 代谢的限速步骤。有人提出,唾液中 NO 的摄取与无机碘(I)竞争发生。因此,本研究旨在检验补充 I 会干扰 NO 代谢并削弱膳食 NO 补充后血压降低的假设。9 名健康成年人(4 名男性,平均年龄±标准差,20±1 岁)报到实验室进行初始基线评估(对照),并在随机交叉实验中连续 6 天补充 140 mL·天富含硝酸盐的甜菜根汁(8.4 mmol·天)和 198 mg 葡萄糖酸钾·天(硝酸盐),以及 140 mL·天富含硝酸盐的甜菜根汁和 450 μg 碘化钾·天(硝酸盐+碘)。与对照和 NIT 试验相比,硝酸盐+碘组的唾液 [I] 更高(P<0.05)。与对照试验相比,硝酸盐和硝酸盐+碘试验中的唾液和血浆 [NO] 和 [NO] 更高(P<0.05)。与硝酸盐试验相比,硝酸盐+碘试验中的血浆 [NO] 更高(474±127 对 438±117 μM),唾液-血浆 [NO] 比值更低(14±6 对 20±6 μM),表明唾液中 NO 的摄取较低(P<0.05)。硝酸盐和硝酸盐+碘试验之间的血浆和唾液 [NO] 没有差异(P>0.05)。与对照相比,硝酸盐(106±13 mmHg)和硝酸盐+碘(106±11 mmHg)试验中的收缩压均低于对照(112±13 mmHg)(P<0.05),但硝酸盐和硝酸盐+碘试验之间无差异(P>0.05)。总之,同时摄入 NO 和 I 会干扰唾液中 NO 的摄取,但与单独摄入 NO 相比,唾液和血浆中 [NO] 的增加和血压的降低相似。因此,增加膳食 I 的摄入(全球多个国家建议以此作为预防甲状腺功能减退的措施)似乎不会影响增加膳食 NO 摄入带来的血压降低效果。